Metsera Inc (MTSR)

Jul 22, 2025

Metsera Inc. Stock Analysis and ForecastHigh-margin investment plays - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

What drives Metsera Inc. stock priceFree Advanced Stock Screener Access - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

What analysts say about Metsera Inc. stockFree Consultation - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Is Metsera Inc. a good long term investmentFree High-Return Strategy Alerts - jammulinksnews.com

Jul 22, 2025

Jul 20, 2025

Metsera price target raised to $45 from $38 at BofA - TipRanks

Jul 20, 2025

Jul 20, 2025

Metsera, Inc.: Buy Rating Affirmed Amid Promising Clinical Data and Strategic Positioning - TipRanks

Jul 20, 2025

Jul 19, 2025

ATAI Impresses, CDTX Navigates With Confidence, MTSR Builds Momentum, COGT Keeps Scaling The Summit… - RTTNews

Jul 19, 2025

Jul 18, 2025

Metsera soars 75% after InvestingPro’s April undervalued signal By Investing.com - Investing.com Nigeria

Jul 18, 2025

Jul 16, 2025

Metsera (MTSR) Presented at the 85th Scientific Sessions of the American Diabetes Association - MSN

Jul 16, 2025

Jul 15, 2025

Why Metsera Inc. stock attracts strong analyst attentionFast Gains With Reduced Risk - Newser

Jul 15, 2025

Jul 15, 2025

What makes Metsera Inc. stock price move sharplyLow Risk Profit Ideas - Newser

Jul 15, 2025

Jul 15, 2025

How Metsera Inc. stock performs during market volatility2x Return Forecast - Newser

Jul 15, 2025

Jul 10, 2025

Metsera Inc. (MTSR) Is a Great Choice for 'Trend' Investors, Here's Why - sharewise.com

Jul 10, 2025

Jul 10, 2025

Wall Street Analysts See a 55.72% Upside in Metsera Inc. (MTSR): Can the Stock Really Move This High? - Yahoo Finance

Jul 10, 2025

Jun 24, 2025

Wall Street Analysts See an 89.66% Upside in Metsera Inc. (MTSR): Can the Stock Really Move This High? - Yahoo Finance

Jun 24, 2025

Jun 22, 2025

Metsera, Inc.(NasdaqGS: MTSR) added to S&P Biotechnology Select Industry Index - MarketScreener

Jun 22, 2025

Jun 21, 2025

Metsera (NASDAQ:MTSR) Now Covered by Analysts at Wells Fargo & Company - Defense World

Jun 21, 2025

Jun 20, 2025

Metsera stock initiated at overweight by Wells Fargo on obesity drug - Investing.com Nigeria

Jun 20, 2025

Jun 17, 2025

Metsera Unveils First-in-Class Once-Monthly Amylin Candidate MET-233i’s Positive Phase 1 Results - MSN

Jun 17, 2025

Jun 13, 2025

Cantor Fitzgerald reiterates Metsera stock rating on strong MET-233i results - Investing.com Nigeria

Jun 13, 2025

Jun 12, 2025

Promising Results Of Amylin Analogs In Obesity: Metsera Case Review (NASDAQ:MTSR) - Seeking Alpha

Jun 12, 2025

Jun 12, 2025

Cantor Fitzgerald Predicts Metsera FY2026 Earnings - Defense World

Jun 12, 2025

Jun 11, 2025

13 Biotech Stocks with Huge Upside Potential - Insider Monkey

Jun 11, 2025

Jun 11, 2025

Metsera Shows Rising Price Performance With Jump To 92 RS Rating - MSN

Jun 11, 2025